Drug Profile
Research programme: anti-infectives - Cetek
Alternative Names: Anti-infectives research programme - CetekLatest Information Update: 20 Jul 2007
Price :
$50
*
At a glance
- Originator Cetek Corporation; Essential Therapeutics [CEASED]
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Mycoses; Viral infections
Most Recent Events
- 20 Jul 2007 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 20 Jul 2007 Discontinued - Preclinical for Mycoses in USA (unspecified route)
- 20 Jul 2007 Discontinued - Preclinical for Viral infections in USA (unspecified route)